GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » EV-to-FCF

Zentek (TSXV:ZEN) EV-to-FCF : -14.83 (As of May. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zentek EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Zentek's Enterprise Value is C$147.07 Mil. Zentek's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was C$-9.92 Mil. Therefore, Zentek's EV-to-FCF for today is -14.83.

The historical rank and industry rank for Zentek's EV-to-FCF or its related term are showing as below:

TSXV:ZEN' s EV-to-FCF Range Over the Past 10 Years
Min: -125.14   Med: -11.78   Max: -7.62
Current: -14.83

During the past 13 years, the highest EV-to-FCF of Zentek was -7.62. The lowest was -125.14. And the median was -11.78.

TSXV:ZEN's EV-to-FCF is ranked worse than
100% of 359 companies
in the Medical Devices & Instruments industry
Industry Median: 27.9 vs TSXV:ZEN: -14.83

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), Zentek's stock price is C$1.50. Zentek's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.110. Therefore, Zentek's PE Ratio for today is At Loss.


Zentek EV-to-FCF Historical Data

The historical data trend for Zentek's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek EV-to-FCF Chart

Zentek Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.14 -15.98 -109.33 -29.95 -12.95

Zentek Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.16 -12.95 -14.86 -14.64 -14.34

Competitive Comparison of Zentek's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Zentek's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zentek's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zentek's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Zentek's EV-to-FCF falls into.



Zentek EV-to-FCF Calculation

Zentek's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=147.070/-9.918
=-14.83

Zentek's current Enterprise Value is C$147.07 Mil.
Zentek's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-9.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zentek  (TSXV:ZEN) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Zentek's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.50/-0.110
=At Loss

Zentek's share price for today is C$1.50.
Zentek's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.110.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Zentek EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Zentek's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zentek (TSXV:ZEN) Business Description

Traded in Other Exchanges
Address
24 Corporate Ct, Guelph, ON, CAN, N1G 5G5
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
Executives
Francis Jacques Dubé Director

Zentek (TSXV:ZEN) Headlines

From GuruFocus

Zendesk Announces Date of Second Quarter 2022 Financial Results

By Business Wire Business Wire 07-19-2022

Zendesk Announces Date of Third Quarter 2022 Financial Results

By Business Wire Business Wire 10-20-2022

WESTFIELD CAPITAL MANAGEMENT CO LP Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-14-2022

First Growth Investment Manager LP Cuts Portfolio Down to Size in 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-21-2022

Top 5 2nd Quarter Trades of Sylebra Capital Ltd

By GuruFocus Research GuruFocus Editor 08-17-2022

Top 5 2nd Quarter Trades of Jana Partners

By GuruFocus Research GuruFocus Editor 08-15-2022

Top 5 4th Quarter Trades of TOKIO MARINE ASSET MANAGEMENT CO LTD

By GuruFocus Research GuruFocus Editor 01-26-2023

Top 5 3rd Quarter Trades of TIG Advisors, LLC

By GuruFocus Research GuruFocus Editor 11-15-2022